Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China's cancer treatment market?

Research and development costs run up against a ceiling over treatment prices, a very pertinent concern in China, where the government is anxious to keep health care affordable, in keeping with its socialist principle of governance

Related Keywords

China ,Beijing ,Hong Kong ,Luo Jiarong ,Hunan ,Shanghai ,Chinese ,Bristol Myer Opdivo ,Innovent Biologics ,Bristol Myers Squibb ,Michael Yu Dechao ,Wu Yu ,Junshi Biosciences ,Eli Lilly ,Merck Keytruda ,Shanghai Pharmaceuticals Holding ,Us Federal Drug Administration ,Shanghai Junshi Biosciences ,Communist Party Led ,Myers Squibb ,United States Based ,Christmas Eve ,Drug Administration ,Shanghai Pharmaceuticals ,China Merchants ,